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Abstract: Several mitochondrial proteins, such as adenine nucleotide translocase (ANT),
aspartate/glutamate carrier, dicarboxylate carrier, and uncoupling proteins 2 and 3, are suggested to
have dual transport functions. While the transport of charge (protons and anions) is characterized
by an alteration in membrane conductance, investigating substrate transport is challenging.
Currently, mainly radioactively labeled substrates are used, which are very expensive and require
stringent precautions during their preparation and use. We present and evaluate a fluorescence-based
method using Magnesium Green (MgGrTM), a Mg2+-sensitive dye suitable for measurement in
liposomes. Given the different binding affinities of Mg2+ for ATP and ADP, changes in their
concentrations can be detected. We obtained an ADP/ATP exchange rate of 3.49 ± 0.41 mmol/min/g
of recombinant ANT1 reconstituted into unilamellar liposomes, which is comparable to values
measured in mitochondria and proteoliposomes using a radioactivity assay. ADP/ATP exchange
calculated from MgGrTM fluorescence solely depends on the ANT1 content in liposomes and is
inhibited by the ANT-specific inhibitors, bongkrekic acid and carboxyatractyloside. The application
of MgGrTM to investigate ADP/ATP exchange rates contributes to our understanding of ANT function
in mitochondria and paves the way for the design of other substrate transport assays.
Keywords: fluorescence; magnesium greenTM fluorescent dye; radioactivity; model systems;
recombinant adenine nucleotide translocase; reconstitution into liposomes; mitochondria
1. Introduction
In mitochondria, members of the solute carrier family 25 (SLC25) transport metabolically relevant
substrates across the inner mitochondrial membrane [1–6]. The most prominent member is adenine
nucleotide translocase (ANT, also AAC for ADP/ATP carrier protein), which exchanges ADP and
ATP across the inner mitochondrial membrane to maintain energy balance in cells. The kinetics of
ANT-mediated ADP/ATP exchange is mainly investigated using radioactive isotopes, such as 3H,
14C, or 32P. The utilization of radioactively labeled substances demands extensive precautions in
the preparation of samples, conduct of measurements and waste disposal of radioactive material,
which makes such experiments very tedious and limited to specially equipped laboratories.
A promising method to analyze ADP/ATP exchange in cells and mitochondria uses the fluorescent
dye magnesium green (MgGrTM), which is sensitive to Mg2+ and benefits from the different binding
affinities of Mg2+ to ATP and ADP [7]. However, the precision of the technique when used in cells is
diminished by several limitations. The concentration of ATP and ADP in mitochondria is sensitive
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to the metabolic state and is significantly altered already under mild physiological and metabolic
stress. Magnesium is the second most abundant cation in the cell and is involved in more than
300 cellular and mitochondrial enzymatic reactions, including metabolism of nucleic acids, lipids
and proteins. In particular, Mg2+ participates in reactions involving the formation and use of ATP.
Therefore, the assay specificity in living mitochondria is difficult to achieve and the estimation of the
free Mg2+ concentration in mitochondria is delicate and may rapidly change during measurements [8].
The activity of another mitochondrial carrier, such as the ATP-Mg/Pi carrier, cannot be sorted out and
may alter the kinetics of ANT-mediated ADP/ATP exchange in cells [9].
The application of recombinant ANT reconstituted into proteoliposomes allows to precisely
predefine experimental conditions and the ADP/ATP exchange is directly dependent on the ANT
activity. However, the model system is typically combined with the use of radioactively labeled
substrates [10–12]. Although the fluorescence technique is more convenient, because it does not require
radionucleotides, a protocol to measure ANT-mediated ADP/ATP exchange in proteoliposomes was
not described, yet.
The goals of the study were: (i) to establish a fluorescence assay for measuring the ANT1 transport
rate in proteoliposomes and compare to the radioactivity method; (ii) to show the correct transport
function of the recombinant ANT1 produced in Escherichia coli (E.coli); and (iii) to evaluate the activation
and inhibition kinetics of ANT1-mediated ADP/ATP transport.
2. Materials and Methods
2.1. Chemicals
Sodium sulfate (Na2SO4), 2-(N-morpholino)ethanesulfonic acid (MES), tris(hydroxymethyl)-
aminomethane (Tris), ethylene glycol-bis(β-aminoethyl ether)-N,N,N’,N’-tetraacetic acid (EGTA),
bovine serum albumin (BSA), arachidonic acid (AA), magnesium dichloride (MgCl2), guanosine
triphosphate (GTP), adenosine tri- and diphosphate (ATP, ADP), Sephadex™ G-50 size exclusion
beads, bongkrekic acid (BA), carboxyatractyloside (CATR), DL-dithiothreitol (DTT), chloramphenicol,
sodium lauryl sulfate, TritonTM X 114, bromophenol blue and β-mercaptoethanol were purchased from
Sigma–Aldrich GmbH (Neustadt, Germany). Sodium dihydrogen phosphate dihydrate (NaH2PO4) and
EDTA were obtained from Merck (Darmstadt, Germany). 1,2-dioleoyl-sn-glycero-3-phosphocholine
(DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and cardiolipin (CL) were from
Avanti Polar Lipids Inc. (Alabaster, AL, USA). Chloroform, sodium chloride (NaCl), tryptone/peptone
ex casein, yeast extract, kanamycin sulfate, isopropyl β-D-thiogalactoside, ethylene glycol, TritonTM
X 100, glycerin and sodium dodecyl sulfate (SDS) were obtained from Carl Roth GmbH (Karlsruhe,
Germany). N-Octylpolyoxyethylene came from BACHEM (Bubendorf, Switzerland). Magnesium
GreenTM, Pentapotassium salt, cell impermeant (MgGrTM) was purchased from Thermo Fisher Scientific
(Waltham, MA, USA) and [2,5′,8-3H] ATP from Perkin Elmer (A = 1 mCi; Waltham, MA, USA).
2.2. Cloning, Isolation and Reconstitution of Murine ANT1 and UCP1
Murine ANT1 (Slc25a4)-containing proteoliposomes were produced according to a previously
established protocol for mUCP1 [13]. The open reading frame of ANT1 was obtained as a cDNA clone
(IRAVp968G119D; BioCat, Heidelberg, Germany) and inserted between NdeI and BamHI restriction
sites of the expression vector pET24a (Novagen, Darmstadt, Germany). Expression plasmids were
transformed into the E. coli expression strain Rosetta (DE3; Novagen). Bacteria were grown in
DYT-media containing 16 mg/mL peptone ex casein, 10 mg/mL yeast extract, 5 mg/mL NaCl, 25 µg/mL
kanamycin sulfate and 34 µg/mL chloramphenicol until an optical density OD600 of 0.5 was reached.
Protein expression was induced using 1 mM isopropyl β-D-thiogalactoside. Bacteria were harvested
after 3 h. To isolate inclusion bodies, bacterial pellets were re-suspended in 100 mM Tris, 5 mM
EDTA, pH 7.5 (TE–buffer) containing 1 mM DTT and Protease Inhibitor Cocktail for bacterial extracts
(Sigma–Aldrich, Vienna, Austria) and disrupted by applying a high-pressure homogenizer One Shot
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(Constant Systems Limited, Daventry, UK) at 1 kbar. The cell lysate was centrifuged for 30 min at
15,000× g and the pellet was re-suspended in 150 mM NaH2PO4 at pH 7.9, 25 mM EDTA, 5% ethylene
glycol (PA-buffer) plus 2% Triton X-100, 1 mM DTT and protease inhibitor. Inclusion bodies were
obtained after centrifugation at 14,000× g for 20 min.
For protein reconstitution, 1 mg protein from inclusion bodies was solubilized in 100 mM Tris
at pH 7.5, 5 mM EDTA, 10% glycerin (TE/G-buffer) containing 2% sodium lauryl sulfate and 1 mM
DTT, and mixed gradually with 50 mg lipid mixture (DOPC, DOPE and CL; 45:45:10 mol%) dissolved
in TE/G-buffer plus 1.3% Triton X-114, 0.3% n-octylpolyoxyethylene, 1 mM DTT and GTP to a final
concentration of 2 mM. After 3 h of incubation, the mixture was concentrated to a fifth using Amicon
Ultra-15 filters (Millipore, Schwalbach, Germany), dialyzed for 2 h against TE/G buffer with 1 mg/mL
BSA and 1 mM DTT, and then two times without DTT in a total time of at least 12 h. The mixture
was dialyzed three times against assay buffer (50 mM Na2SO4, 10 mM MES, 10 mM Tris, 0.6 mM
EGTA at pH 7.35) for buffer exchange. To eliminate aggregated and unfolded proteins, the dialysate
was centrifuged at 14,000 × g for 10 min and run through a 0.5 g hydroxyapatite-containing column
(Bio-Rad, Munich, Germany). Non-ionic detergents were removed by application of Bio-Beads SM-2
(Bio-Rad). Proteoliposomes were stored at −80 ◦C. The protein concentration in proteoliposomes
was measured using a Micro BCATM Protein Assay Kit (Thermo Fisher Scientific, Prod. #23235,
Waltham, MA, USA). Protein purity was verified by SDS–polyacrylamide gel electrophoresis (PAGE)
plus silver staining.
Production, purification, and reconstitution of recombinant murine UCP1 into proteoliposomes
followed a previously published protocol [14].
2.3. SDS–PAGE and Silver Staining
For SDS–PAGE, approximately 0.5 µg of inclusion body proteins solubilized in 1% SDS or
proteoliposomes was mixed with loading buffer containing bromophenol blue to a concentration of
0.025 M Tris pH 6.0, 2.5 % glycerin, 1% SDS, and 1% β-mercaptoethanol, and degraded at 97 ◦C for
10 min. Samples and Precision Plus Protein Dual Color Standards (Bio-Rad, Vienna, Austria) were
loaded on 15% SDS–PAGE gels and electrophoresis was performed at 80 V for 30 min for at least 2 h at
120 V. Silver staining of the gel was performed according to [15]. The purity of recombinant ANT1 and
UCP1 is shown in Figure S1.
2.4. Preparation of Unilamellar (Proteo-) Liposomes
DOPC, DOPE and CL lipids were mixed in chloroform at 45:45:10 mol%, respectively,
and evaporated under nitrogen flow until they assembled as a thin film on the wall of a glass
vial. Buffer containing 50 mM Na2SO4, 10 mM Tris, 10 mM MES, and 0.6 mM EGTA at pH = 7.34
was added to the lipids and the solution vortexed until the lipids were fully dissolved. Liposomes
and ANT1- or UCP1-containing proteoliposomes were then diluted to a final lipid concentration of
1 mg/mL. Unilamellar (proteo-) liposomes were formed by a Mini-Extruder system (Avanti Polar Lipids
Inc., Alabaster, AL, USA) using a membrane filter with a pore diameter of 100 nm (Figure S2).
2.5. Calibration of Fluorescence Intensity of MgGrTM
For calibration, the fluorescence intensity of 3 µM MgGrTM fluorescent dye was measured at Mg2+
concentrations from 0 to 1.2 mM in 0.2 mM increments in buffer solution. The binding constant of
Mg2+ to MgGrTM was estimated by the fit of an exponential function to the data [7]. The fluorescence
signal of 3 µM MgGrTM in the presence of 1 mM Mg2+ and 0, 0.25, 0.5, 1, 2, and 3 mM ATP or ADP was
first converted to a free Mg2+ concentration in buffer. Binding constants of ADP/ATP to Mg2+ were
determined by fitting a Michaelis–Menten equation to the data [7]. All measurements were performed
in a 96-well plate (TPP, Trasadingen, Switzerland) with VWell = 300 µL. Fluorescence intensity was
measured as counts per second in a plate reader (EnSpire® Multimode Plate Reader, Perkin Elmer,
Waltham, MA, USA) with excitation and detection wavelengths of 506 and 531 nm, respectively.
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2.6. Fluorescence-Based ADP/ATP Exchange Rate Measurements
Prior to extrusion, (proteo-) liposomes were incubated with 3 µM MgGrTM, 1 mM MgCl2 and
2 mM ATP for at least 20 min at T = 4 ◦C. After extrusion, extraliposomal substrates were removed
by size-exclusion chromatography. The inhibitors CATR and BA were added before extrusion and
after size-exclusion at the concentrations indicated in the figure descriptions to account for the random
orientation of proteins in liposomes. Samples were added to a 96-well plate and the time course of
fluorescence intensity was recorded in a plate reader. After the signal stabilized, ADP/ATP exchange
was initiated by the addition of 2 mM ADP to the buffer solution. The concentration of ATP inside the
(proteo-) liposomes was calculated from the fluorescence signal using the measured binding constants
of Mg2+ to MgGrTM, ATP, and ADP.
2.7. Radioactivity-Based Exchange Rate Measurements
Prior to extrusion, 2 mM ADP was added to (proteo-)liposomes. After extrusion, external ADP
was removed by size-exclusion chromatography. ADP/ATP exchange was initiated by the addition of
2 mM 3H labeled-ATP and stopped after size exclusion chromatography. Radioactivity was measured
by liquid scintillation counting (Tri-Carb 2100TR, Perkin Elmer). For inhibition, 100 µM of each of the
ANT-specific inhibitors, CATR and BA, were simultaneously added prior to 3H-ATP to account for the
random orientation of ANT1 in the membrane.
2.8. Statistical Analysis
Data analysis and fitting were performed by Sigma Plot 12.5 (Systat Software GmbH,
Erkrath, Germany) and are displayed as the mean ± standard deviation (SD) of at least three
independent measurements.
3. Results
3.1. Calibration of MgGrTM Fluorescence Intensity to ADP/ATP Concentration and Determination of Related
Binding Affinities
We used the fluorescent dye MgGrTM, whose emission efficiency significantly increases in the
presence of free Mg2+ (Figure 1A). Since Mg2+ possesses different binding affinities for MgGrTM, ATP,
and ADP, it serves as a mediator between fluorescence intensity and ATP concentration. To convert
fluorescence intensity to purine nucleotide (PN) concentration, the binding affinities of Mg2+ for
MgGrTM, ATP, and ADP were measured: KMg,MgGr = 1.18 ± 0.11 mM (Figure 1B), KMg,ATP =
0.44 ± 0.09 mM (Figure 1C) and KMg,ADP = 2.23 ± 0.50 mM (Figure 1C).
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Figure 1. Working principles for ADP/ATP exchange measurements using MgGrTM fluorescent dye.
(A) A schema demonstrating the principle of the method. Mg2+ binds to MgGrTM, ATP and ADP
with different affinities that results to the formation of fluorescent (Mg-MgGrTM) or non-fluorescent
(Mg-ATP) complexes. (B) Dependence of fluorescence intensity of MgGrTM on Mg2+ concentration.
The line is the fit of an exponential rise to maximum function to the data. (C) Calculated concentration of
free Mg2+ agai st purine nucleotides (PNs) ATP (ope circles) and ADP (orange squares) concentr s.
The initial concentration of Mg2+ was 1 mM. Lines derive from data fittings to the Michaelis–Menten
function. In all measurements, the buffer contained 50 mM Na2SO4, 10 mM Tris, 10 mM MES and
0.6 mM EGTA at pH = 7.34 and T = 297 K. The concentration of MgGrTM was 3 µM. Data are shown as
the mean ± SD of at least three independent measurements.
3.2. Conversion of MgGrTM Fluorescence Intensity to ADP/ATP Exchange Rate Values
(Proteo-)liposomes were filled with MgGrTM, Mg2+ and ATP, and external substrates were
removed by size exclusion chromatography (Figure 2A, left image). The addition of ADP initiated ATP
exchange with ADP through ANT1. This led to Mg2+ binding to MgGrTM (Figure 2A, right image)
increasing fluorescence intensity with time (Figure 2B).
The Mg2+ conce tration inside proteoliposomes was directly determine usi g previously
determined binding affinities (Figure 2C). The time course of the ATP decrease inside proteoliposomes
was calculated based on the assumption that the ratio of ANT1-mediated ADP/ATP exchange was
1:1 (Figure 2D). From an exponential fit of the data, we calculated the exchange rates of knone =
7.8 ± 0.6 µM/min, kANT1 = 35.3 ± 3.2 µM/min and kANT1+BA/CATR = 14.7 ± 1.0 µM/min (Figure 2E).
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Figure 2. ADP/ATP exchange rate measurements using a fluorescence-based assay. (A) A scheme
of the fluorescence-based assay of (proteo-)liposomes with internal Magnesium Green (MgGr)TM.
The measurements started with the addition of ADP at time point t = 2 min (arrows). (B) Time
dependence of the fluorescence intensity, (C) calculated [Mg2+], and (D) calculated [ATP] in the
presence (red triangles) and absence (open circles) of ANT1, and in the presence of BA and CATR
(red diamonds). (E) Maximal ADP/ATP exchange rate of liposomes (open bars) and ANT1 containing
proteoliposomes in the absence (red bars) and presence (dark red bars) of ANT1 inhibitors (BA and
CATR). Values were obtained as a fit parameter from (D). In all measurements, the buffer contained
50 mM Na2SO4, 10 mM Tris, 10 mM MES and 0.6 mM EGTA at pH = 7.34 and T = 297 K. Lipid
membranes were made of DOPC, DOPE and CL (45:45:10 mol%). The lipid concentration was
1.0 mg/mL and the liposome diameter was approximately 100 nm. Concentrations of ATP, ADP, Mg2+
and MgGrTM were 2 mM, 2 mM, 1 mM and 3 µM, respectively. The concentrations of ANT1 and
inhibitors (BA, CATR) were 8.67 µg/mL and 100 µM, respectively. Data are shown as the mean ± SD of
at least three independent measurements.
3.3. Measurements of ADP/ATP Exchange Using Radioactivity Assay
To evaluate the MgGrTM fluorescence assay, we performed radioactivity measurements with
3H-label d ATP. We measured the time course of 3H-ATP uptake into (proteo-) liposomes, which were
initially filled with ADP (Figure 3A, left image). By the addi ion of 3H-ATP, ANT1-mediated ADP/ATP
exchange was initiated (Figure 3A, right image).
After 1, 20 and 60 min, the (proteo-) liposome containing solution was added to a size exclusion
chromatography column and extra-liposomal 3H-ATP was removed. The flow-through was collected,
a scintillation cocktail added, and the amount of 3H-ATP determined by liquid scintillation counting
(Figure 3B). From the fit of an exponential function to the data sets, we calculated initial ATP uptake
rates of knone = 2.6 ± 0.9 µM/min, kANT1 = 28.4 ± 10.9 µM/min, and kANT1+BA/CATR = 7.2 ± 2.1 µM/min
(Figure 3C).
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(BA) and carboxyatractyloside (CATR, squares), and in the absence of protein (circl ). i es are fits of
an exponential rise to maximum function to the data. (C) Values of the DP/ATP exchange rate as
determined from the fit parameters in (B). In all measurements, the buffer contained 50 mM Na2SO4,
10 mM Tris, 10 mM MES, and 0.6 mM EGTA at pH = 7.34 and T = 297 K. Lipid membranes were made
of 45:45:10 mol% of DOPC, DOPE and CL, respectively. The lipid concentration was 1.0 mg/mL and the
liposome diameter was approximately 100 nm. The concentration of ANT1 was 8.67 µg/mL and the
concentrations of ATP, ADP, BA and CATR were 2 mM, 2 mM, 100 µM and 100 µM, respectively. Data
are shown as the mean ± SD of at least three independent measurements.
3.4. Proof of Specificity of ANT1-Mediated ADP/ATP Exchange Rate Measured in Both Assays
In order to test whether the estimated exchange rates were ANT1-specific, we measured exchange
rates at different ANT1 concentrations for both assays (Figure 4A). From a linear fit of the data sets, we
obtained specific exchange rate values of k = 3.49 ± 0.41 mmol/min/g in the fluorescence assay and
k = 2.90 ± 0.47 mmol/min/g in the radioactivity assay.Biomolecules 2020, 10, x FOR PEER REVIEW 8 of 12 
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Figure 4. Determination f ANT1 specificity f /ATP exchange. ( ) ADP/ATP exchange rates
at different ANT1 concentrations measured in the fluorescent (green circles) and radioactive (open
diamonds) assay. Lines are a linear fit to the data. (B) Exchange rates measured in the absence of
protein (open bars), and in the presence of ANT1 (red bars) and uncoupling protein 1 (UCP1, blue
bars) in liposomes measured with Magnesium Green (MgGr)TM (left bar of each data set) and 3H
radioactivity (right bar of each data set). ANT1 and UCP1 were used at 8.67 µg/mL and 7.07 µg/mL,
respectively. In all measurements, the buffer contained 50 mM Na2SO4, 10 mM Tris, 10 mM MES and
0.6 mM EGTA at pH = 7.34 and T = 297 K. Lipid membranes were made of 45:45:10 mol% of DOPC,
DOPE and CL, respectively. The lipid concentration was 1.0 mg/mL and the liposo e diameter was
approximately 100 nm. Concentrations of ATP, ADP, Mg2+ and MgGrTM were 2 mM, 2 mM, 1 mM and
3 µM, respectively. Data are shown as the mean ± SD of at least three independent measurements.
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We further analyzed the specificity of both assays to ANT1, replacing ANT1 with UCP1,
which binds but does not transport ATP and ADP. We measured exchange values of kUCP1 =
2.12 ± 0.57 mmol/min/g in the fluorescence assay and kUCP1 = 0.30 ± 0.10 mmol/min/g in the
radioactivity assay (Figure 4B and Figure S3). Whereas the MgGrTM assay measured the ADP/ATP
ratio indirectly via free Mg2+, the amount of 3H-ATP was determined directly by liquid scintillation
counting. Therefore, we assume that the alteration of the ADP/ATP ratio due to the presence of UCP1 in
proteoliposomes may have resulted in a false-positive ADP/ATP exchange response in the fluorescence
assay, which is absent in the radioactivity assay.
3.5. Inhibition of ANT1-Mediated ADP/ATP Exchange
To test the suitability of the fluorescence-based assay, we measured the ADP/ATP exchange with
increasing concentrations of the ANT specific inhibitors, BA and CATR. The addition of BA and
CATR decreased ADP/ATP exchange in a dose-dependent manner (Figure 5A). From an exponential
function fit of the data, we obtained EC50 values of 55.6 ± 17.0 µM for BA and 32.5 ± 5.9 µM for
CATR (Figure 5B), and maximum inhibition values of 91.1 ± 12.9% for BA and 83.1 ± 4.7% for CATR,
respectively (Figure 5C).
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Figure 5. Dose-dependence of ANT1-mediated ADP/ATP exchange in the presence of specific inhibitors
(CATR and BA). (A) Dose-response curves of ANT1-mediated ADP/ATP exchange rates measured
with a fluorescence assay in the presence of bongkrekic acid (BA, circles) and carboxyatractyloside
(CATR, triangles) normalized to the full, uninhibited rate. Lines are fits of an exponential function to
the data. (B) EC50 and (C) maximum inhibition by BA and CATR obtained as fit parameters from (A).
In all measurements, the buffer contained 50 mM Na2SO4, 10 mM Tris, 10 mM MES and 0.6 mM EGTA
at pH = 7.34 and T = 297 K. Lipid membranes were made of 45:45:10 mol% of DOPC, DOPE and CL,
respectively. The lipid concentration was 1.0 mg/mL and the liposome diameter was approximately
100 nm. The concentration of ANT1 was 6.70 µg/mL, and the concentrations of ATP, ADP, Mg2+,
and Magnesium Green (MgGr)TM were 2 mM, 2 mM, 1 mM and 3 µM, respectively. Data are shown as
the mean ± SD of at least three independent measurements.
4. Discussion
In the present study, we established a fluorescence-based method for proteoliposomes, which was
developed initially for isolated mitochondria [7,16], and measured ANT1-dependent ADP/ATP
exchange, which was inhibited by the ANT-specific inhibitors, BA and CATR. Although the radioactive
assay measures the ATP amount in the proteoliposomes directly, its experimental use is unattractive
due to the extensive precautions required to prevent radioactive contamination.
Other methods exist to continuously determine ADP/ATP exchange kinetics: (i) directly, using
fluorescent derivatives of ATP or ADP [17] or (ii) indirectly, using luminescence of firefly luciferase [18],
or fluorescence by NADP+ reduction [19,20]. However, their transfer to the model system is not as
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straightforward as the MgGrTM fluorescence assay. The luminescence assay requires firefly luciferase,
Mg2+ and oxygen for the conversion of ATP to AMP and pyrophosphate (PPi) [21], which alters the
ADP/ATP ratio, increases AMP content and produces PPi, which is also supposed to interact with ANT
activity [22]. Furthermore, the optimal working range is limited in terms of temperature and ionic
strength; a variation in these conditions may decrease the sensitivity of measurements. Fluorescence
measurements of NADP+ depend on glucose and enzymes, which are present in isolated mitochondria
but have to be added in a model system. The use of fluorescent adenosine nucleotide derivatives
suffers from substrate specificity of the ANT-mediated ADP/ATP exchange, since the full structures
of the adenosine nucleotides are recognized [23]. Small variations in PN structure are supposed
to significantly alter binding and transport of ATP and ADP [24–29], and further depend on the
configuration of ANT [30].
The MgGrTM based fluorescence method was primarily described for measurements in cell
systems or isolated mitochondria. However, its precision is diminished by environmental stress,
metabolic state and the presence of further mitochondrial carriers, such as the ATP-Mg/Pi carrier,
which substantially alter the assay-relevant substrates. Here, we worked out the fluorescence technique
for the model system of recombinant ANT1 reconstituted into proteoliposomes. This system benefits
from clear predefined experimental conditions which allowed to calibrate fluorescence intensity in
relation to Mg2+, ATP and ADP more precisely. Since ANT neither transports Mg2+ nor MgGrTM,
the fluorescence intensity solely reflects alterations of the ADP/ATP ratio in the liposomes, and directly
correlates with the ADP/ATP exchange activity of ANT.
A disadvantage of the model system is the low protein to lipid ratio of the reconstituted protein
(<10 µg/mg lipid) compared to mitochondria, and the ratio of the transported substrate to bulk substrate
is unfavorable. We compensated for the low signal-to-noise ratio by the presence of Mg2+ and MgGrTM
inside the (proteo-) liposomes. The presence of ATP inside the (proteo-) liposomes in the initial state is
preferred since its exchange for ADP increases fluorescence, which is in contrast to a potential loss of
intensity by photobleaching of MgGrTM or leakage of Mg2+ through the membrane.
A further limitation originates from the kinetics of binding of Mg2+ to ADP and ATP. The amount
of ATP and ADP must be set in order to significantly change the free Mg2+ concentration in liposomes
upon their exchange. ATP and ADP concentrations below approximately 200 µM or above 3 mM
(Figure 1C) will not significantly alter the free Mg2+ concentration and fluorescence intensity, and the
ADP/ATP exchange cannot be further resolved by fluorescent dye.
Radioactivity assays are the gold standard to measure transport kinetics of membrane carriers with
sufficient sensitivity. In order to verify the method and show the functionality of recombinant ANT1,
we performed a standard radioactivity assay and obtained an exchange rate of 2.90 ± 0.47 mmol/min/g.
The value was obtained at 24 ◦C in the absence of a transmembrane potential. In the literature,
the measured exchange values of ANT vary significantly and strongly depend on the experimental
conditions used, the tissue, the protein origin and the mitochondrial transmembrane potential.
In isolated mitochondria, a strong temperature dependency of exchange kinetics was measured with
rates ranging from 40 µmol/min/g at 10 ◦C, up to 550 µmol/min/g at 37 ◦C in rat liver, and from
100 µmol/min/g to 1.8 mmol/min/g in bovine heart [31]. Similar values were obtained in rat heart
mitochondria by [32] and from isolated ANT from bovine heart mitochondria reconstituted into
liposomes [10,33]. With the advent of yeast (y)ANTs (especially the yANT2 isoform) as a tool to
investigate the transport function of ANT, the exchange rates were significantly raised by one order of
magnitude to 7.5 mmol/min/g at 10 ◦C [11] and 65.7 mmol/min/g at room temperature [12].
Measurements performed with MgGrTM in isolated rat mitochondria from different tissues
produced ATP turnover rates from 5 s−1 in heart to 99 s−1 in liver, measured at 37 ◦C,
and a transmembrane potential of −160 to −170 mV [7]. Our measured exchange rate of
3.49 ± 0.41 mmol/min/g corresponds to an ATP turnover rate of ≈ 1.75 s−1 and is substantially lower,
but may be explained by the lower temperature and absence of a transmembrane potential.
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Generally, fluorescent and radioactive assays have their advantages and disadvantages.
The fluorescence assay is less expensive and allows for continuous measurements of the same sample,
which decreases statistical variation. However, ANT-mediated exchange rates are measured indirectly
via the free Mg2+ concentration as a response to alterations in the ADP/ATP ratio. Thus, a precise
calibration of the system is mandatory. The radioactivity assay directly measures the 3H-ATP
concentration in liposomes, but suffers from the increased effort to obtain a similar time course of
ADP/ATP exchange. Furthermore, sample variation is increased as a further technical step is needed to
remove external 3H-ATP at each time point.
Apart from substrate transport function, several members of the SLC25 family, including
ANT [34,35], aspartate/glutamate carrier [36], dicarboxylate carrier [37], and uncoupling proteins [6],
are suggested to have dual transport functions and are additionally involved in the fatty acid
(FA)-mediated transport of protons. In this context, substrate transport reflects a major control for the
protein’s functionality. For ANT1, the ease of the fluorescent assay allows for quick functionality control.
Of special interest is the possible use of the fluorescence assay to simultaneously measure
FA-induced proton leak electrophysiologically and substrate transport fluorometrically. The parallel
investigation will give new insights into the interplay between the two functions of ANT,
exchanging ATP against ADP under coupled conditions, and transporting FA-mediated protons
under uncoupled conditions.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-273X/10/5/685/s1,
Figure S1: Silver staining of recombinant murine uncoupling protein 1 (mUCP1) and murine adenine nucleotide
translocase 1 (mANT1) reconstituted into liposomes; Figure S2: Sizes of liposomes after extrusion through 100 nm
filters; Figure S3: Time course of the ADP/ATP exchange in presence of mANT1 and mUCP1, and the absence
of protein.
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